Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.28 +0.02 (+7.69%)
At close: Nov 6, 2026 · 4:00 PM EST

Anebulo Pharmaceuticals (ANEB) Total Debt (2020)

Updated

Anebulo Pharmaceuticals (ANEB) posted Total Debt of $201,286 for fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Anebulo Pharmaceuticals (ANEB) Total Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 44.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 80.90 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 32.35 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 26.23 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 62.67 Bn
10 Anebulo Pharmaceuticals 11.50 Mn -32.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 201,286.00
API Access

Anebulo Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ANEB&period=max&api_key=YOUR_API_KEY